NASDAQ:PHAR

Finance·Investment·Market Analysis·NASDAQ:PHAR·News

Pharvaris Trades Flat as Investors Wait for June Data Update

Pharvaris shares edged up 0.5% to $30.00 on Nasdaq Friday after the company announced new clinical data on its hereditary angioedema drug deucrictibant will be presented at a major allergy conference in June. The company plans a U.S. filing for the drug’s immediate-release capsule in the first half of 2026 and expects Phase 3 prevention data in the third quarter.

May 29, 2026

Top 3 ASX Dividend Shares to Buy in June for Reliable Income
May 29, 2026, 3:14 PM EDT. June presents income investors with opportunities in three top ASX dividend shares: APA Group, Telstra, and Transurban. APA Group, a key player in Australia's energy infrastructure, offers a forecast 5.7% dividend yield for FY 2027. Telstra, Australia's leading telco, provides essential mobile connectivity with a 4.1% forward dividend yield, supported by its dominant network. Transurban operates critical toll roads in Australia and North America, with expected dividend yield also at 4.1% in FY 2027. These shares offer resilient cash flows and defensive characteristics, appealing amid varied market conditions.